ΔNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding

Biochemical and Biophysical Research Communications

Volumn 369, Issue 4, 2008, Pages 994-1000

  Ichikawa, Tomoe ^a,b   Suenaga, Yusuke ^a,c   Koda, Tadayuki ^b   Ozaki, Toshinori ^a,c   Nakagawara, Akira ^a,c  

^a CHIBA CANCER CENTER   (Japan)

^b HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Np63; BMP 7; Keratinocyte; Matrilin 2; Migration; Wound healing

Indexed keywords

GENE PRODUCT; MATRILIN 2; OSTEOGENIC PROTEIN 1; PROTEIN DELTA NP63; PROTEIN P63; SCLEROPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN; DNA BINDING PROTEIN; GLYCOPROTEIN; MATN2 PROTEIN, HUMAN; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EPIDERMIS; GENE; GENE TARGETING; HUMAN; HUMAN CELL; KERATINOCYTE; MATRILIN 2 GENE; MORPHOGENESIS; P63 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; WOUND; WOUND HEALING; CELL LINE; CELL MOTION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; INJURY; METABOLISM; PHYSIOLOGY; PROMOTER REGION;

MUS;

BONE MORPHOGENETIC PROTEINS; CELL LINE; CELL MOVEMENT; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; KERATINOCYTES; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 41149118361     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.128     Document Type: Article

References (25)

1. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., and McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2 (1998) 305-316
2. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., and Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
3. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
4. Ikawa S., Nakagawara A., and Ikawa Y. p53 family genes: structural comparison, expression and mutation. Cell Death Differ. 6 (1999) 1154-1161
5. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., and McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398 (1999) 714-718
6. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398 (1999) 708-713
7. Candi E., Rufini A., Terrinoni A., Dinsdale D., Ranalli M., Paradisi A., De Laurenzi V., Spagnoli L.G., Catani M.V., Ramadan S., Knight R.A., and Melino G. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 13 (2006) 1037-1047
8. Koster M.I., Dai D., and Roop D.R. Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle 6 (2007) 269-273
9. Parsa R., Yang A., McKeon F., and Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Invest. Dermatol. 113 (1999) 1099-1105
10. Sommer M., Poliak N., Upadhyay S., Ratovitski E., Nelkin B.D., Donehower L.A., and Sidransky D. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle 5 (2006) 2005-2011
11. Wu G., Osada M., Guo Z., Fomenkov A., Begum S., Zhao M., Upadhyay S., Xing M., Wu F., Moon C., Weastra W.H., Koch W.M., Mantovani R., Califano J.A., Ratovitski E., Sidransky D., and Trink B. ΔNp63α up-regulates the Hsp70 gene in human cancer. Cancer Res. 65 (2005) 758-766
12. Kip2 expression by p63. Cell Cycle 4 (2005) 1625-1631
13. Deak F., Piecha D., Bachrati C., Paulsson M., and Kiss I. Primary structure and expression of matrilin-2, the closest relative of cartilage matrix protein within the von Willebrand factor type A-like module superfamily. J. Biol. Chem. 272 (2007) 9268-9274
14. Wagener R., Ehlen H.W., Ko Y.P., Kobbe B., Mann H.H., Sengle G., and Paulsson M. The matrilins-adaptor proteins in the extracellular matrix. FEBS Lett. 579 (2005) 3323-3329
15. Deak F., Wagener R., Kiss I., and Paulsson M. The matrilins: a novel family of oligomeric extracellular matrix proteins. Matrix Biol. 18 (1999) 55-64
16. Piecha D., Wiberg C., Morgelin M., Reinhardt D.P., Deak F., Maurer P., and Paulsson M. Matrilin-2 interacts with itself and with other extracellular matrix proteins. Biochem. J. 367 (2002) 715-721
17. Goetsch S.C., Hawke T.J., Gallarde T.D., Richardson J.A., and Garry D.J. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics 14 (2003) 261-271
18. Szabo E., Lodi C., Korpos E., Batmunkh E., Rottenberger Z., Deak F., Kiss I., Tokes A.M., Lotz G., Laszlo V., Kiss A., Schaff Z., and Nagy P. Expression of matrilin-2 in oval cells during rat liver regeneration. Matrix Biol. 26 (2007) 554-560
19. Hudson L.G., and McCawley L.J. Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc. Res. Tech. 43 (1998) 444-455
20. Kusanagi K., Inoue H., Ishidou Y., Mishima H.K., Kawabata M., and Miyazono K. Characterization of a bone morphogenetic protein-responsive Smad binding element. Mol. Biol. Cell 11 (2000) 555-565
21. Yan W., and Chen X. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells. Cancer Res. 67 (2007) 9117-9124
22. Franzen A., and Heldin N.E. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem. Biophys. Res. Commun. 285 (2001) 773-781
23. WAF1/Cip1. J. Cell Physiol. 204 (2005) 260-272
24. Barbieri C.E., Tang L.J., Brown K.A., and Pietenpol J.A. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res. 66 (2006) 7589-7597
25. Bamberger C., Hafner A., Schwale H., and Werner S. Expression of different p63 variants in healing skin wounds suggests a role of p63 in reepithelialization and muscle repair. Wound Repair Regen. 13 (2005) 41-50